Deals with historical, clinical and neurobiological aspects of movement disorders commonly associated with neuroleptic drugs.The most widely prescribed group of psychotropic drugs, neuroleptics are indispensable in the management of a majority patients with schizophrenia, as well as other psychoses, yet they are associated with troublesome adverse effects, of which movement disorders are the most serious.This book deals with historical, clinical and neurobiological aspects of tardive dyskinesia and related movement disorders such as parkinsonism, dystonia and akathisia. Sections are also devoted to the measurement of tardive dyskinesia, to geographical and ethnic differences, and to management with novel neuroleptic agents and biofeedback.The most widely prescribed group of psychotropic drugs, neuroleptics are indispensable in the management of a majority patients with schizophrenia, as well as other psychoses, yet they are associated with troublesome adverse effects, of which movement disorders are the most serious.This book deals with historical, clinical and neurobiological aspects of tardive dyskinesia and related movement disorders such as parkinsonism, dystonia and akathisia. Sections are also devoted to the measurement of tardive dyskinesia, to geographical and ethnic differences, and to management with novel neuroleptic agents and biofeedback.Although generally beneficial, neuroleptics often cause adverse effects, of which movement disorders are the most serious in terms of frequency and persistence. This book was prepared with the aim of improving understanding and clinical management of these treatment-caused conditions. The authors address the historical, clinical and neurobiological aspects of the most serious of these conditions, tardive dyskinesia, as well as related movement disorders such as parkinsonism, dystonia and akathisia. The authors also devote sections of the text to the measurement of tardive dyskinesia, geographical and ethnic variablelC.